Evidence map›Paper›PMID 40649264›Full record

ArticleMolecules (Basel, Switzerland)2025

Phytochemical Analysis and Chymotrypsin Inhibitory Potential of

Bartosz Rył, Izabela Jasicka-Misiak

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bartosz RyłInstitute of Chemistry, University of Opole, 48 Oleska Str., 45-052 Opole, Poland.ORCID 0000-0002-3909-8872
Izabela Jasicka-MisiakInstitute of Chemistry, University of Opole, 48 Oleska Str., 45-052 Opole, Poland.ORCID 0000-0001-7788-5482

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chymotrypsin inhibitors were initially considered mainly as anti-nutritional factors. However, the potential for their use as therapeutics has been recognized, particularly in the control of cancer, neurodegenerative diseases, and inflammatory processes. The search for new, effective, and safe chymotrypsin inhibitors has become important not only for food and feed safety reasons, but also in the search for new compounds with potential for use in the pharmaceutical industry. Oxidative stress is also an integral etiological factor in the development of the aforementioned pathological conditions. Antioxidants supplied with food can have an impact on reducing the probability of developing these diseases. Herbaceous plants are a valuable reservoir of biologically active chemical compounds, which can show both inhibitory effects against a number of enzymatic reactions and have antioxidant activity. The compounds found within them are also often characterized by higher bioavailability and safety than their synthetic analogs. In the present study, phytochemical characterization of plant materials

Indexed as

ChymotrypsinPhytochemicalsPlant ExtractsAntioxidantsBiological AssayChromatography, Thin LayerFlavonoidsPhenolsAntioxidantsChymotrypsinFlavonoidsPhenolsPhytochemicalsPlant Extractsantioxidant activityGalium aparine L.Galium verum L.HPTLC-chymotrypsin inhibitionHPTLC-DPPH•Solidago canadensis L.Solidago virgaurea L.

Identifiers

PMID40649264
PMCPMC12250678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.